2021. 9. 21. · My fund has revealed a class of investor that most venture capitalists aren’t even talking to. Most of these investors are already sold on the idea of psychedelics, but I’ve also used my YouTube channel to post some broader educational content for people less familiar with the field, like my Psychedelic Therapy FAQ. 2022. 10. 11. · Insights Widest with the analysis, Proactive gives perspectives that others don't. Deep dive. PharmaDrug looking to develop and commercialise a range of psychedelics,. 2022. 4. 14. · When it comes to psychedelic stocks, MindMed (NASDAQ: MNMD), (NEO: MMED) has long been the darling of the retail investor community. With a vast psychedelic-medicine. Psychedelic-assisted therapy, PAT, is an approach to healing that combines traditional therapeutic modalities with the use of psychedelic substances in a supervised and intentional setting to induce an expanded state of consciousness for the purposes of healing and growth. Psychedelics are a class of hallucinogenic substances that trigger non. 2021 Psychedelic Investor Guide. Editor | Curator-August 8, 2021. 2021 Psychedelic Investor Conference. ... Curator-August 25, 2022. Psychedelic Drug Helped People with Alcohol use Disorder Reduce Drinking, Study Shows (Today) Psilocybin,... View Post. Stan Grof, Psychedelic's Elder Statesman. INTERVIEW Editor | Curator-August 15, 2022. Dina was one of the first investors in psychedelic therapeutics space and is on the founding team of the largest psychedelic research center. Dina is also a serial entrepreneur, angel investor (Coinbase, Boom Supersonic, Mattermost), ex-McKinsey / J.P. Morgan, MBA Harvard Business School and MS in Psychology at CIIS. 2022. 10. 12. · With an Active Portfolio and Additional Capital to Deploy, Palo Santo Fund is Positioned to Accelerate the Development of Breakthrough Psychedelic Therapies for the Treatment of Mental. 2021. 1. 21. · Noting this development, market researcher Data Bridge recently projected that the psychedelics sector could bring in a whopping $6.85 billion by 2027. No surprise that investors. Institutional Analyst Inc. announced the release of the 2021 Psychedelic Investor Guide on Monday, October 18th. The Psychedelic Investor Guide is the most comprehensive and easy to use guide covering the rapidly growing Psychedelic investment landscape. Forty-six of the Leading Companies in the Sector are Listed. Each Profile Contains: Stock chart.